I. Barillot

7.0k total citations · 3 hit papers
117 papers, 4.0k citations indexed

About

I. Barillot is a scholar working on Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Radiation. According to data from OpenAlex, I. Barillot has authored 117 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 40 papers in Obstetrics and Gynecology and 33 papers in Radiation. Recurrent topics in I. Barillot's work include Endometrial and Cervical Cancer Treatments (40 papers), Advanced Radiotherapy Techniques (33 papers) and Ovarian cancer diagnosis and treatment (20 papers). I. Barillot is often cited by papers focused on Endometrial and Cervical Cancer Treatments (40 papers), Advanced Radiotherapy Techniques (33 papers) and Ovarian cancer diagnosis and treatment (20 papers). I. Barillot collaborates with scholars based in France, United States and Netherlands. I. Barillot's co-authors include Christine Haie-Méder, Bradley A. Erickson, Christian Kirisits, Richard Pötter, Marisol De Brabandere, Peter Petrow, Isabelle Dumas, Stefan Lang, Jason Rownd and An Nulens and has published in prestigious journals such as New England Journal of Medicine, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

I. Barillot

110 papers receiving 3.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology

2006 1.2k citations I. Barillot et al. Radiotherapy and Oncology profile →
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation

2001 693 citations Jean-Claude Horiot, I. Barillot et al. profile →
Definition of the prostate in CT and MRI: a multi-observer study

1999 447 citations I. Barillot et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
I. Barillot	1.5k	1.5k	1.4k	1.1k	983	117	4.0k
Subir Nag	1.0k 0.7×	1.6k 1.0×	1.5k 1.1×	807 0.8×	1.9k 1.9×	78	4.2k
Carlos A. Perez	937 0.6×	1.7k 1.1×	1.2k 0.8×	830 0.8×	2.4k 2.5×	93	5.3k
Mary Ann Lockett	1.1k 0.7×	1.1k 0.7×	1.3k 0.9×	1.1k 1.0×	1.6k 1.7×	46	3.6k
Rachelle Lanciano	2.3k 1.5×	1.6k 1.1×	765 0.5×	556 0.5×	1.0k 1.0×	109	4.1k
Gabriella Macchia	769 0.5×	1.2k 0.8×	1.0k 0.7×	812 0.8×	1.4k 1.5×	318	3.6k
Carla C. Wárlám-Rodenhuis	2.4k 1.6×	1.2k 0.8×	782 0.5×	553 0.5×	443 0.5×	35	4.9k
Revathy B. Iyer	1.7k 1.1×	1.5k 1.0×	324 0.2×	875 0.8×	768 0.8×	108	4.0k
Ina M. Jürgenliemk‐Schulz	3.1k 2.0×	1.6k 1.1×	1.7k 1.2×	1.4k 1.3×	1.1k 1.1×	115	5.0k
Shyam Kishore Shrivastava	774 0.5×	859 0.6×	982 0.7×	634 0.6×	962 1.0×	138	2.6k
P. Koper	2.2k 1.5×	826 0.5×	2.0k 1.4×	1.1k 1.0×	2.3k 2.3×	59	5.5k

Countries citing papers authored by I. Barillot

Since Specialization

Citations

This map shows the geographic impact of I. Barillot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Barillot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Barillot more than expected).

Fields of papers citing papers by I. Barillot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Barillot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Barillot. The network helps show where I. Barillot may publish in the future.

Co-authorship network of co-authors of I. Barillot

This figure shows the co-authorship network connecting the top 25 collaborators of I. Barillot. A scholar is included among the top collaborators of I. Barillot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Barillot. I. Barillot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pointreau, Y., et al.. (2023). Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity. Cancer/Radiothérapie. 27(3). 225–232. 2 indexed citations

Dissaux, Gurvan, Dimitris Visvikis, Ronrick Da‐ano, et al.. (2019). Pretreatment ¹⁸F-FDG PET/CT Radiomics Predict Local Recurrence in Patients Treated with Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer: A Multicentric Study. Journal of Nuclear Medicine. 61(6). 814–820. 137 indexed citations

Barillot, I., D. Antoni, J. Biau, et al.. (2018). Bases référentielles de la radiothérapie en conditions stéréotaxiques pour les tumeurs ou métastases bronchopulmonaires, hépatiques, prostatiques, des voies aérodigestives supérieures, cérébrales et osseuses. Cancer/Radiothérapie. 22(6-7). 660–681. 12 indexed citations

Mahé, M.-A., I. Barillot, & B. Chauvet. (2016). Recommandations en radiothérapie externe et curiethérapie (Recorad) : 2e édition. Cancer/Radiothérapie. 20. S4–S7. 9 indexed citations

Barillot, I., et al.. (2016). Patients porteurs d’un stimulateur cardiaque ou d’un défibrillateur implantable. Cancer/Radiothérapie. 20. S256–S258. 5 indexed citations

Cao, Kim, R. Mazeron, & I. Barillot. (2015). Suivi après radiothérapie pour un cancer du col utérin. Cancer/Radiothérapie. 19(6-7). 590–596.

Barillot, I., et al.. (2014). Impact of post operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: Results of the phase II RTCMIENDOMETRE French multicentre trial. Radiotherapy and Oncology. 111(1). 138–143. 40 indexed citations

Barillot, I., et al.. (2014). Stratégies d’évaluation de la réponse après irradiation stéréotaxique des cancers bronchiques primitifs et des métastases pulmonaires. Cancer/Radiothérapie. 18(4). 308–312. 3 indexed citations

Thureau, S., et al.. (2013). Obésité et irradiation : difficultés techniques, toxicité et efficacité. Cancer/Radiothérapie. 17(5-6). 543–548. 6 indexed citations

10.

Chauvet, B., et al.. (2012). Développement professionnel continu en oncologie radiothérapie. Cancer/Radiothérapie. 16(5-6). 392–397. 1 indexed citations

11.

Trédaniel, Jean, F. Mornex, I. Barillot, et al.. (2011). Protocole IFCT 0803 – Étude de phase II évaluant l’association de cétuximab à une radiothérapie et chimiothérapie concomitante par cisplatine et pémétrexed dans le traitement des cancers bronchiques non à petites cellules non épidermoïdes de stade III, inopérables. Revue des Maladies Respiratoires. 28(1). 51–57. 4 indexed citations

12.

Pointreau, Y., Antoine Loubière, Fabrice Denis, & I. Barillot. (2010). Cancer du col utérin. Cancer/Radiothérapie. 14. S147–S153. 8 indexed citations

13.

Barillot, I., et al.. (2009). Segmentation automatique du volume tumoral des cancers pulmonaires non à petites cellules sur la 18F-FDG TEP-TDM en vue d’un traitement par radiothérapie. Médecine Nucléaire. 33(7). 440–449. 1 indexed citations

14.

Coatmeur, Olivier, G. Truc, I. Barillot, Jean-Claude Horiot, & P. Maingon. (2004). Treatment of T1–T2 rectal tumors by contact therapy and interstitial brachytherapy. Radiotherapy and Oncology. 70(2). 177–182. 22 indexed citations

15.

Maingon, P., et al.. (2004). Les contraintes aux organes à risque en radiothérapie par modulation d'intensité des cancers ORL. Cancer/Radiothérapie. 8(4). 234–247. 17 indexed citations

16.

Maingon, P., O. Chapet, I. Barillot, & P. Romestaing. (2004). Complément d’irradiation du lit tumoral : l’âge de raison. Cancer/Radiothérapie. 8(1). 33–38. 5 indexed citations

17.

Bartelink, H., P Poortmans, Jacques Borger, et al.. (2002). Minder lokale recidieven van borstkanker door extra lokale bestralingsdosis na mammasparende chirurgie: 5-jaarsresultaten van een klinische trial. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 146(9). 416–423. 1 indexed citations

18.

Barillot, I., et al.. (2000). Bilan de l'utilisation de l'imagerie électronique. Cancer/Radiothérapie. 4. 1 indexed citations

19.

Truc, G., Jean-Claude Horiot, P. Maingon, & I. Barillot. (2000). Le cancer épidermoïde de l'oropharynx. Bulletin du Cancer. 87(12). 9–20. 2 indexed citations

20.

Barillot, I., J.C. Horiot, Jean Cuisenier, et al.. (1993). Carcinoma of the cervical stump: A review of 213 cases. European Journal of Cancer. 29(9). 1231–1236. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact